EAM Investors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,779
| Closed | -$1.7M | – | 341 |
|
|
2020
Q1 | $1.7M | Buy |
11,779
+551
| +5% | +$79.5K | 0.53% | 81 |
|
|
2019
Q4 | $2.3M | Buy |
11,228
+2,078
| +23% | +$425K | 0.5% | 61 |
|
|
2019
Q3 | $735K | Sell |
9,150
-19,783
| -68% | -$1.59M | 0.19% | 204 |
|
|
2019
Q2 | $2.73M | Sell |
28,933
-8,984
| -24% | -$848K | 0.67% | 33 |
|
|
2019
Q1 | $3.24M | Buy |
37,917
+511
| +1% | +$43.7K | 0.8% | 14 |
|
|
2018
Q4 | $2.1M | Sell |
37,406
-25,771
| -41% | -$1.45M | 0.57% | 43 |
|
|
2018
Q3 | $5.17M | Buy |
+63,177
| New | +$5.17M | 0.77% | 7 |
|